Yahoo Web Search

Search results

1. • 

     Vtama dosage: Form, strength, how to apply it, and more

     Medical News Today· 5 days ago

     Vtama (tapinarof) is a brand-name drug that’s prescribed for plaque psoriasis in adults. Vtama comes...

2. • 

     Psoriasis After COVID-19: Is There a Connection?

     Healthline· 2 days ago

     A few studies suggest some people with psoriasis may experience flares after getting COVID-19 or the vaccine. Psoriasis is a common autoimmune condition...

3. • 

     Vtama: Side effects and how to manage them

     Medical News Today· 3 days ago

     Vtama (tapinarof) is a brand-name topical cream that’s prescribed to treat plaque psoriasis in adults. As with other drugs, Vtama can cause side effects...

4. • 

     Clobex and dosage: Strength, forms, when to use, and more

     Medical News Today· 4 days ago

     Doctors may prescribe Clobex to treat plaque psoriasis. If your doctor prescribes Clobex spray for...

5. • 

     Tapinarof may mark Dermavant’s first atopic dermatitis approval

     Clinical Trials Arena via Yahoo Finance· 3 days ago

     Tapinarof is an aryl hydrocarbon receptor (AhR) receptor modulator that has been observed to have...

6. • 

     Pharma Stock Roundup: LLY's CFO Departs, ABBV, AZN Drugs Get CHMP Approval

     Zacks via Yahoo Finance· 2 days ago

     It combines darunavir, J&J’s HIV-1 protease inhibitor, and cobicistat, Gilead...colitis (UC)....

7. • 

     My patients can’t afford two crucial medications, and Big Pharma should be held accountable

     Colorado Newsline via Yahoo News· 3 days ago

     As a physician, I am encouraged and impressed with the work that Colorado’s Prescription Drug...

8. • VENTYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Ventyx Biosciences, Inc. on Behalf of...

     Morningstar· 6 days ago

     Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Ventyx Biosciences, Inc. (NASDAQ: VTYX) on behalf of long-term stockholders ...

9. • These Biotech Stocks Hit New Highs, Did You Reap The Rewards?

     RTT News· 2 days ago

     The following compilation represents a selection of stocks featured on our website that reached new 52-week high levels during the current week. Protagonist is a clinical-stage biopharmaceutical ...

10. • 

      AbbVie Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU - AbbVie (NYSE:ABBV), ALX Oncology...

      Benzinga· 6 days ago

      The recommended treatment regime with AbbVie's Skyrizi involves an intravenous induction dose of...